Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...
The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback